Dianthus Therapeutics (DNTH) Total Current Liabilities (2017 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Total Current Liabilities of $30.7 million for Q4 2025, up 66.55% year-over-year from $18.5 million in Q4 2024, and up 28.83% quarter-over-quarter from $23.9 million in Q3 2025.
Dianthus Therapeutics (DNTH) Total Current Liabilities (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' Total Current Liabilities history runs 9 years deep, the most recent figure standing at $30.7 million for Q4 2025.
- In Q4 2025, Total Current Liabilities rose 66.55% year-over-year to $30.7 million; the TTM figure through Dec 2025 stood at $30.7 million (up 66.55% YoY), while the FY2025 annual figure was $30.7 million, up 66.55% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $30.7 million, up from $23.9 million in the prior quarter.
- The five-year high for Total Current Liabilities was $30.7 million in Q4 2025, with the low at $4.0 million in Q2 2023.
- The 5-year median for Total Current Liabilities is $11.2 million (2021), against an average of $13.3 million.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities plunged 64.16% in 2023, then surged 148.61% in 2024.
- Dianthus Therapeutics' Total Current Liabilities stood at $10.9 million in 2021, then dropped by 24.28% to $8.2 million in 2022, then rose by 17.09% to $9.6 million in 2023, then surged by 91.59% to $18.5 million in 2024, then jumped by 66.55% to $30.7 million in 2025.
- Business Quant data shows DNTH's Total Current Liabilities at $30.7 million in Q4 2025, $23.9 million in Q3 2025, and $20.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Dianthus Therapeutics | 4.97 Bn | 4.57 Bn | - | 30.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.73 Mn |
| Sep 30, 2025 | 23.86 Mn |
| Jun 30, 2025 | 20.09 Mn |
| Mar 31, 2025 | 16.95 Mn |
| Dec 31, 2024 | 18.45 Mn |
| Sep 30, 2024 | 15.71 Mn |
| Jun 30, 2024 | 10.03 Mn |
| Mar 31, 2024 | 8.96 Mn |
| Dec 31, 2023 | 9.63 Mn |
| Sep 30, 2023 | 13.08 Mn |
| Jun 30, 2023 | 4.03 Mn |
| Mar 31, 2023 | 5.98 Mn |
| Dec 31, 2022 | 8.23 Mn |
| Sep 30, 2022 | 12.92 Mn |
| Jun 30, 2022 | 11.26 Mn |
| Mar 31, 2022 | 14.09 Mn |
| Dec 31, 2021 | 10.86 Mn |
| Sep 30, 2021 | 10.15 Mn |
| Jun 30, 2021 | 11.08 Mn |
| Mar 31, 2021 | 9.21 Mn |